Inventor · disambiguated record
Peter J. Stengel
Also filed as: STENGEL PETER · STENGEL PETER J
20 granted patents·10 pending applications·222 citations·filing 2004–2025
94Inventor score
Files withARRAY BIOPHARMA INC10BLATT LAWRENCE M4NOVARTIS AG4PELOTON THERAPEUTICS INC4ROCHE PALO ALTO LLC3
Top patents by PatentIndex Score
30 records- 0198US7491794B2Macrocyclic compounds as inhibitors of viral replicationINTERMUNE INC·Filed 2005·Granted Feb 17, 2009·147 cites·1 claims
- 0291US9676730B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 13, 2017·9 cites·15 claims
- 0390US9790190B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 17, 2017·7 cites·23 claims
- 0490US9309204B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Apr 12, 2016·7 cites·16 claims
- 0589US9416110B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 16, 2016·10 cites·4 claims
- 0689US7674810B21,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymeraseROCHE PALO ALTO LLC·Filed 2006·Granted Mar 9, 2010·8 cites·15 claims
- 0788US9382212B1Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2015·Granted Jul 5, 2016·6 cites·24 claims
- 0887US9238627B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2013·Granted Jan 19, 2016·7 cites·14 claims
- 0987US7479489B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2005·Granted Jan 20, 2009·7 cites·41 claims
- 1084US9598376B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2016·Granted Mar 21, 2017·3 cites·14 claims
- 1184US9562016B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2015·Granted Feb 7, 2017·3 cites·16 claims
- 1282US9980944B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2017·Granted May 29, 2018·2 cites·12 claims
- 1381US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 1479US2025326711A1Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereofPELOTON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1578US10398683B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2017·Granted Sep 3, 2019·1 cites·23 claims
- 1673US10729678B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2019·Granted Aug 4, 2020·0 cites·1 claims
- 1768US12358870B2Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereofPELOTON THERAPEUTICS INC·Filed 2019·Granted Jul 15, 2025·0 cites·12 claims
- 1868US2009111982A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 1967US2009286843A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2065US2009105471A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2165US2009111969A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2264US7968707B2Retroviral protease inhibiting compoundsABBOTT LAB·Filed 2007·Granted Jun 28, 2011·0 cites·12 claims
- 2358US2018258054A1Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 2456US2016152576A9Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 2555US2005130954A1AKT protein kinase inhibitorsFiled 2004·Application pending·0 cites
- 2647US7531534B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2007·Granted May 12, 2009·0 cites·15 claims
- 2744US10329288B2Process for preparing a compoundGENENTECH INC·Filed 2014·Granted Jun 25, 2019·0 cites·20 claims
- 2844US9790206B2Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereofARRAY BIOPHARMA INC·Filed 2014·Granted Oct 17, 2017·0 cites·35 claims
- 2944US2022081407A1Methods of preparing substituted indanesPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3042US2018049995A1Hif-2-alpha inhibitor polymorphsPELOTON THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter J. Stengel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →